The cytochrome P450s catalyze the oxidation of a wide variety of xenobiotic and endogenous compounds. Biochemical, biophysical, and computational approaches are applied to examine the structure-function relationships which govern the interactions of P450s with substrates, inhibitors, membrane lipids, and microsomal proteins. Since these interactions modulate P450 activity, elucidation of their molecular mechanism will aid in (1) clarifying the mechanism of P450-mediated drug and carcinogen metabolism; (2) defining the role of individual P450s in the metabolism of endogenous and environmental chemicals; and (3) development of specific P450 inhibitors. The flash photolysis technique was used to examine the kinetics of CO binding to P450. Although monoexponential kinetics were observed for P450 2E1, P450s 3A4 and 1A1 exhibited nonexponential kinetics. The Maximum Entropy Method was applied to obtain a kinetic distribution profile that corresponds to the conformational landscape. This statistical approach yielded P450-specific conformer distributions that were altered by substrate addition. These results suggest that P450 structure may be best viewed as a distribution of different conformers. Homology modeling was employed to generate a structure for human P450 1A2. On the basis of proposed active groups in the substrate binding site, we computationally searched a small molecule database for complementary molecules. This approach successfully identified several P450 inhibitors, thus providing further validation of our P450 homology model.

Agency
National Institute of Health (NIH)
Institute
Division of Basic Sciences - NCI (NCI)
Type
Intramural Research (Z01)
Project #
1Z01BC005318-20
Application #
6761532
Study Section
(LM)
Project Start
Project End
Budget Start
Budget End
Support Year
20
Fiscal Year
2002
Total Cost
Indirect Cost
Name
Basic Sciences
Department
Type
DUNS #
City
State
Country
United States
Zip Code
Michl, Josef; Scharf, Bruce; Schmidt, Anna et al. (2006) PNC-28, a p53-derived peptide that is cytotoxic to cancer cells, blocks pancreatic cancer cell growth in vivo. Int J Cancer 119:1577-85
Duncan, Thomas; Chen, James M; Friedman, Fred K et al. (2004) Comparison of molecular dynamics averaged structures for complexes of normal and oncogenic ras-p21 with SOS nucleotide exchange protein, containing computed conformations for three crystallographically undefined domains, suggests a potential role of these Protein J 23:217-28
Chie, Lyndon; Adler, Victor; Friedman, Fred K et al. (2004) An effector peptide from glutathione-S-transferase-pi strongly and selectively blocks mitotic signaling by oncogenic ras-p21. Protein J 23:235-8
Chie, Lyndon; Friedman, Fred K; Duncan, Thomas et al. (2004) Loop domain peptides from the SOS ras-guanine nucleotide exchange protein, identified from molecular dynamics calculations, strongly inhibit ras signaling. Protein J 23:229-34
Friedman, Fred K; Robinson, Richard C; Dai, Renke (2004) Molecular modeling of mammalian cytochrome P450s. Front Biosci 9:2796-806
Bustin, Michael; Robinson, Richard C; Friedman, Fred K (2004) Immunochemical analysis of chromatin. Methods Enzymol 376:209-20
Dai, R; Pincus, M R; Friedman, F K (2000) Molecular modeling of mammalian cytochrome P450s. Cell Mol Life Sci 57:487-99
Smith, S V; Koley, A P; Dai, R et al. (2000) Conformational modulation of human cytochrome P450 2E1 by ethanol and other substrates: a CO flash photolysis study. Biochemistry 39:5731-7
Omata, Y; Dai, R; Smith, S V et al. (2000) Synthetic peptide mimics of a predicted topographical interaction surface: the cytochrome P450 2B1 recognition domain for NADPH-cytochrome P450 reductase. J Protein Chem 19:23-32
Wei, X; Dai, R; Zhai, S et al. (1999) Inhibition of human liver cytochrome P-450 1A2 by the class IB antiarrhythmics mexiletine, lidocaine, and tocainide. J Pharmacol Exp Ther 289:853-8